Faecal matters: How transplanting gut bacteria and their viruses impacts cardiometabolic disease

K. Wortelboer

Faecal matters: How transplanting gut bacteria and their viruses impacts cardiometabolic disease

Research output: PhD Thesis › Phd-Thesis - Research and graduation internal

Abstract

This thesis explores the potential of the gut microbiota in cardiometabolic diseases (CMD), a growing global health concern.
The first part focuses on faecal microbiota transplantation (FMT) as potential treatment for CMD. FMT is increasingly used as experimental treatment for diseases beyond recurrent Clostridioides difficile infections (rCDI). However,

Original language	English
Qualification	Doctor of Philosophy
Awarding Institution	University of Amsterdam
Supervisors/Advisors	Nieuwdorp, Max, Supervisor Herrema, Hilde, Supervisor Kemper, Marleen, Co-supervisor de Jonge, Patrick, Co-supervisor Kemper, E.M., Co-supervisor, External person
Award date	2 Nov 2023
Print ISBNs	9789464199208
Publication status	Published - 2023

Access to Document

Cite this

@phdthesis{f38502137f0549ab93b5e0d6a24f7e3b,

title = "Faecal matters: How transplanting gut bacteria and their viruses impacts cardiometabolic disease",

abstract = "This thesis explores the potential of the gut microbiota in cardiometabolic diseases (CMD), a growing global health concern.The first part focuses on faecal microbiota transplantation (FMT) as potential treatment for CMD. FMT is increasingly used as experimental treatment for diseases beyond recurrent Clostridioides difficile infections (rCDI). However,",

author = "K. Wortelboer",

year = "2023",

language = "English",

isbn = "9789464199208",

type = "Phd-Thesis - Research and graduation internal",

school = "University of Amsterdam",

}

TY - THES

T1 - Faecal matters

T2 - How transplanting gut bacteria and their viruses impacts cardiometabolic disease

AU - Wortelboer, K.

PY - 2023

Y1 - 2023

N2 - This thesis explores the potential of the gut microbiota in cardiometabolic diseases (CMD), a growing global health concern.The first part focuses on faecal microbiota transplantation (FMT) as potential treatment for CMD. FMT is increasingly used as experimental treatment for diseases beyond recurrent Clostridioides difficile infections (rCDI). However,

AB - This thesis explores the potential of the gut microbiota in cardiometabolic diseases (CMD), a growing global health concern.The first part focuses on faecal microbiota transplantation (FMT) as potential treatment for CMD. FMT is increasingly used as experimental treatment for diseases beyond recurrent Clostridioides difficile infections (rCDI). However,

UR - https://pure.uva.nl/ws/files/142225463/Licentieovereenkomst_medeondertekend_.pdf

UR - https://pure.uva.nl/ws/files/142225465/Propositions.pdf

M3 - Phd-Thesis - Research and graduation internal

SN - 9789464199208

ER -

Faecal matters: How transplanting gut bacteria and their viruses impacts cardiometabolic disease

Abstract

Access to Document

Other files and links

Cite this